Correction to Lancet Oncol 2019; 20: 827-36

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2019 Jun.

. 2019 Jun;20(6):e293.

doi: 10.1016/S1470-2045(19)30293-1. Epub 2019 May 10.

No abstract available

Erratum for

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
Shitara K, Iwata H, Takahashi S, Tamura K, Park H, Modi S, Tsurutani J, Kadowaki S, Yamaguchi K, Iwasa S, Saito K, Fujisaki Y, Sugihara M, Shahidi J, Doi T. Shitara K, et al. Lancet Oncol. 2019 Jun;20(6):827-836. doi: 10.1016/S1470-2045(19)30088-9. Epub 2019 Apr 29. Lancet Oncol. 2019. PMID: 31047804 Clinical Trial.